This company still has some good long term prospects. It only will take the start of the clinical trial for it to jump. Good new drug potentials and sounds like ceo has been down this road before.....but, I still wish I had sold instead of bought more...ouch!!....when it was in the 8s!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.